""All that money doesn't just buy more stuff, it buys more time," the ad voiceover says, a gentle nod toward rich and powerful longevity enthusiasts such as Sam Altman, Jeff Bezos, and Bryan Johnson. Yet the commercial also argues our "wealth gap is a health gap" and that everyday people should have the same access to high-end biological testing that elite concierge medicine services offer the rich, such as regular blood draws, GLP-1 drugs, and yes, peptides."
"It requires a $350 annual lab membership, which includes tests that measure cardiometabolic health, to assess risk for conditions like heart disease or high cholesterol, and hormone levels. On top of that, customers can pay for Grail's Galleri blood draw at a discounted rate of $700. That's $250 less than the retail price for Galleri, but still $1,050 all in for a test that, based on current data, has limited ability of telling you whether you have early-stage cancer."
Hims & Hers is offering Grail's Galleri multi-cancer blood test as part of a preventive-care package through telehealth. The service requires a $350 annual lab membership that includes cardiometabolic and hormone tests, plus a discounted $700 Galleri blood draw, totaling $1,050. Grail's test analyzes two blood vials to screen for more than 50 cancer types, including pancreatic and ovarian cancers that lack routine screening. More than half of US cancers are currently diagnosed at stages 3 or 4. Current data indicate Galleri has limited ability to reliably detect early-stage cancers. The offering reflects a trend toward proactive, consumer-facing medical testing.
Read at Business Insider
Unable to calculate read time
Collection
[
|
...
]